Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher Albitar

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Personalized Medicine|May 20, 2018
Company Profile: NeoGenomics Laboratories, IncMaher Albitar, Alfred Bacharach
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2025
mRNA Expression in DLBCL Patients who are CD20 Dim With an Eye Towards More Thoughtful Design of R/R Trials, Possibly Incorporating BCMA Bite TherapyBruce Hough, Maher Albitar
Expert Review of Molecular Diagnostics|September 26, 2007
Plasma-based testing as a new paradigm for clinical testing in hematologic diseasesFrancis J Giles, Maher Albitar
Current Molecular Medicine|November 25, 2005
Mammalian target of rapamycin as a therapeutic target in leukemiaFrancis J Giles, Maher Albitar
Cancer Genetics and Cytogenetics|October 19, 2010
Somatic mutations of signaling genes in non-small-cell lung cancerHeather R Sanders, Maher Albitar
Archives of Pathology & Laboratory Medicine|November 29, 2002
Chronic lymphocytic leukemia with t(14;18) and trisomy 12Filiz Sen, Raymond Lai, Maher Albitar
Implant Dentistry|September 12, 2008
Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regenerationDennis Smiler, Muna Soltan, Maher Albitar
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerMaher Albitar, Chenhsiung Yeh, Wanlong Ma
Current Hematology Reports|April 17, 2004
Myelodysplastic syndrome: from morphology to biologyMaher Albitar, Weidong Zhou, Francis Giles
Leukemia & Lymphoma|April 12, 2003
Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromesAlvaro Aguayo, Francis Giles, Maher Albitar
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Personalized Medicine|May 20, 2018
Company Profile: NeoGenomics Laboratories, IncMaher Albitar, Alfred Bacharach
Clinical Lymphoma, Myeloma & Leukemia|February 23, 2025
mRNA Expression in DLBCL Patients who are CD20 Dim With an Eye Towards More Thoughtful Design of R/R Trials, Possibly Incorporating BCMA Bite TherapyBruce Hough, Maher Albitar
Expert Review of Molecular Diagnostics|September 26, 2007
Plasma-based testing as a new paradigm for clinical testing in hematologic diseasesFrancis J Giles, Maher Albitar
Current Molecular Medicine|November 25, 2005
Mammalian target of rapamycin as a therapeutic target in leukemiaFrancis J Giles, Maher Albitar
Cancer Genetics and Cytogenetics|October 19, 2010
Somatic mutations of signaling genes in non-small-cell lung cancerHeather R Sanders, Maher Albitar
Archives of Pathology & Laboratory Medicine|November 29, 2002
Chronic lymphocytic leukemia with t(14;18) and trisomy 12Filiz Sen, Raymond Lai, Maher Albitar
Implant Dentistry|September 12, 2008
Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regenerationDennis Smiler, Muna Soltan, Maher Albitar
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerMaher Albitar, Chenhsiung Yeh, Wanlong Ma
Current Hematology Reports|April 17, 2004
Myelodysplastic syndrome: from morphology to biologyMaher Albitar, Weidong Zhou, Francis Giles
Leukemia & Lymphoma|April 12, 2003
Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromesAlvaro Aguayo, Francis Giles, Maher Albitar
Pageof 22